Introduction {#S0001}
============

The use of synthetic pesticides has been increasing considerably pertaining to enhanced global food demands, vector-borne diseases, pests and their genetically modified resistant species (Sayim *et al.*, [@CIT0019]; Bhushan *et al.*, [@CIT0007]). Pyrethroids represent a class of broad spectrum insecticides, finding their rich utility among all categories of users. Synthetic pyrethroids, the synthetic analogues artificially designed by modifying the basic pyrethrin structure, presently account for about 30% of the insecticidal market worldwide (Soderlund *et al.*, [@CIT0023]; Spencer and Sham, [@CIT0024]; Addy-Orduna *et al.*, [@CIT0002]; Bhushan *et al.,* [@CIT0008]). These pesticides are regarded to be comparatively safe, easily biodegradable and target specific, yet their excessive use can cause serious toxicological manifestations in non-target organisms by very many routes through interference and accumulation in various food chains (Rana *et al.*, [@CIT0016]; Assayed *et al.*, [@CIT0005], Corcellas *et al.,* [@CIT0010]; Bhushan *et al.*, [@CIT0009]). Synthetic pyrethroids fall under two categories, viz. type I and type II, based on the absence and presence of the alpha-cyano group, as well as on neurophysiological alterations in animals following intoxication (Singh *et al.,* [@CIT0022]; Bhushan *et al.*, [@CIT0006]). Cypermethrin is a broadly used type II pyrethroid pesticide having a broad spectrum of application, which in turn enhances its non-target toxicity (Aldana *et al.*, [@CIT0004]; Bhushan *et al* [@CIT0008]).

The present study has therefore been aimed at the evaluation of haematotoxicity of cypermethrin through analysis of total RBC count, haemoglobin concentration, PCV, MCV, MCH, MCHC, ESR, TLC, DLC, along with qualitative analysis of peripheral blood and bone marrow.

Material and Methods {#S0002}
====================

Experimental animal rearing and maintenance {#S20003}
-------------------------------------------

The present study was conducted on seventy-two male albino rats, *Rattus norvegicus*, weighing 110±20 g, eight weeks in age, selected from an inbred colony per the ethical committee of the Department of Zoology, Dr. B.R. Ambedkar University, Agra. The experimental animals were provided standard rat pellet food and water *ad libitum*. The rats were acclimatised to laboratory conditions for two weeks prior to experimentation. Then they were divided into six treatment sets, containing six rats each, which were orally administered cypermethrin mixed with groundnut oil by gavage tube. Controls were also run simultaneously and fed groundnut oil.

Experimental compound {#S20004}
---------------------

Cypermethrin (≈95% purity) obtained from Rallis India Ltd., Mumbai was used as experimental compound in the present study and its LD~50~ was calculated (Finney, [@CIT0012]) as 433.6 mg/kg b.wt. (Pande, [@CIT0015]; Bhushan *et al.*, [@CIT0008]).

Dose administration and sample collection {#S20005}
-----------------------------------------

Technical grade of cypermethrin was orally administered to experimental albino rats of respective sub-sets as per acute \[300 mg/kg b.wt./rat for one day\] and sub-chronic (10.7/7, 10.7/14, 10.7/21 and 10.7/28 mg/kg b. wt. for 7, 14, 21 and 28 days) doses of cypermethrin. Animals of the sixth treatment set were administered a dose of 10.7 mg/kg b. wt./rat for 28 days and thereafter left untreated for the next 22 days. Controls corresponding to each treatment set were run simultaneously. These albino rats were etherised after predetermined time intervals to collect blood from the heart ventricle through a hypodermic needle to analyse various haematological parameters, viz. total red blood cell count (TRBC count), erythrocyte sedimentation rate (ESR), total leukocyte count (TLC), differential leukocyte count (DLC), haemoglobin concentration (Hb. Conc.), packed cell volume (PCV), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH) and mean corpuscular haemoglobin concentration (MCHC) by Beckman Coulter analyzer.

Qualitative changes {#S20006}
-------------------

Bone marrow and blood smears were prepared and stained with Leishman stain for morphological evaluation.

Statistical Analysis {#S20007}
--------------------

Data obtained from haematological studies were statistically analysed for significant difference, if any, by Student\'s "t" test by the software SPSS 11.5 for windows.

Results {#S0008}
=======

Haematological changes {#S20009}
----------------------

Of the haematological parameters observed in the experimental groups and compared with respective control groups, total RBC count, haemoglobin concentration, packed cell volume, mean corpuscular volume, and mean corpuscular haemoglobin decreased significantly, whereas a non-significant decrease was observed in case of mean corpuscular haemoglobin concenteration. Erythrocyte sedimentation rate, total leukocyte count and differential leukocyte count showed an increasing trend following cypermethrin intoxication. These parameters became normalised after the recovery phase of twenty-two days ([Table 1](#T0001){ref-type="table"}--[10](#T0010){ref-type="table"}).

###### 

Effect of Cypermethrin on Total RBC Count (million/mm^3^) in *Rattus norvegicus.*

  S.No.                                                Treatment                                   Treatment duration (Days)   No. of rats treated   Dose (mg/kg b.w.)   Range        Mean±S.E.   \% change   Significance level
  ---------------------------------------------------- ------------------------------------------- --------------------------- --------------------- ------------------- ------------ ----------- ----------- --------------------
  1\.                                                  Control[\*](#TF0001){ref-type="table-fn"}   1                           6                     --                  6.74--6.83   6.77±0.02   −1.5        *p\<*0.05
  2\.                                                  Acute                                       1                           6                     300                 6.60--6.76   6.67±0.07               
  3\.                                                  Control[\*](#TF0001){ref-type="table-fn"}   7                           6                     --                  6.68--6.94   6.83±0.04   −1.02       *p\<*0.05
  4\.                                                  Subchronic                                  7                           6                     10.7                6.52--6.86   6.76±0.05               
  5\.                                                  Control[\*](#TF0001){ref-type="table-fn"}   14                          6                     --                  6.79--6.93   6.87±0.02   −4.22       *p\<*0.01
  6\.                                                  Subchronic                                  14                          6                     10.7                6.10--7.05   6.58±0.02               
  7\.                                                  Control[\*](#TF0001){ref-type="table-fn"}   21                          6                     --                  6.78--6.95   6.87±0.03   −4.37       *p\<*0.001
  8\.                                                  Subchronic                                  21                          6                     10.7                5.33--6.72   6.57±0.21               
  9\.                                                  Control[\*](#TF0001){ref-type="table-fn"}   28                          6                     --                  6.75--6.98   6.84±0.03   −4.68       *p\<*0.001
  10\.                                                 Subchronic                                  28                          6                     10.7                6.42--6.70   6.52±0.06               
                                                                                                                                                                                                              
  Recovery group[\*\*](#TF0002){ref-type="table-fn"}                                                                                                                                                          
                                                                                                                                                                                                              
  a\.                                                  Control[\*](#TF0001){ref-type="table-fn"}   --                          6                     --                  6.74--6.83   6.77±0.02   ±1.46       *p*\>0.05
  b\.                                                  Treated                                     --                          6                     10.7                6.79--6.93   6.87±0.02               

Controls were given groundnut oil only

Recovery group were given oil (a) and cypermethrin (b) treatment for 28 days and effects assessed after 60 days

###### 

Effect of Cypermethrin on Haemoglobin Concentration (g/dl) in *Rattus norvegicus.*

  S.No.                                                Treatment                                   Treatment duration (Days)   No. of rats treated   Dose (mg/kg b.w.)   Range        Mean±S.E.    \% change   Significance level
  ---------------------------------------------------- ------------------------------------------- --------------------------- --------------------- ------------------- ------------ ------------ ----------- --------------------
  1\.                                                  Control[\*](#TF0003){ref-type="table-fn"}   1                           6                     --                  12.2--13.1   12.6±0.7     −4.28       *p\<*0.01
  2\.                                                  Acute                                       1                           6                     300                 10.8--13.4   12.06±0.12               
  3\.                                                  Control[\*](#TF0003){ref-type="table-fn"}   7                           6                     --                  11.0--13.8   12.4±0.16    −3.22       *p\<*0.01
  4\.                                                  Subchronic                                  7                           6                     10.7                11.8--12.3   12.0±0.08                
  5\.                                                  Control[\*](#TF0003){ref-type="table-fn"}   14                          6                     --                  10.0--14.0   12.5±0.22    −7.2        *p\<*0.05
  6\.                                                  Subchronic                                  14                          6                     10.7                11.0--12.5   11.6±0.24                
  7\.                                                  Control[\*](#TF0003){ref-type="table-fn"}   21                          6                     --                  10.8--12.6   12.2±0.15    −4.92       *p\<*0.05
  8\.                                                  Subchronic                                  21                          6                     10.7                9.2--11.4    11.6±0.43                
  9\.                                                  Control[\*](#TF0003){ref-type="table-fn"}   28                          6                     --                  10.8--12.8   12.3±0.17    −6.5        *p\<*0.01
  10\.                                                 Subchronic                                  28                          6                     10.7                10.2--12.1   11.5±0.31                
                                                                                                                                                                                                               
  Recovery group[\*\*](#TF0004){ref-type="table-fn"}                                                                                                                                                           
                                                                                                                                                                                                               
  a\.                                                  Control[\*](#TF0003){ref-type="table-fn"}   --                          6                     --                  11.0--13.0   12.5±0.22    ±0.18       *p*\>0.05
  b\.                                                  Treated                                     --                          6                     10.7                11.2--13.1   12.2±0.7                 

Controls were given groundnut oil only

Recovery group were given oil (a) and cypermethrin (b) treatment for 28 days and effects assessed after 60 days

###### 

Effect of Cypermethrin on Packed Cell Volume (%) in Blood of *Rattus norvegicus.*

  S.No.                                                Treatment                                   Treatment duration (Days)   No. of rats treated   Dose (mg/kg b.w.)   Range    Mean±S.E.    \% change   Significance level
  ---------------------------------------------------- ------------------------------------------- --------------------------- --------------------- ------------------- -------- ------------ ----------- --------------------
  1\.                                                  Control[\*](#TF0005){ref-type="table-fn"}   1                           6                     --                  38--44   41.83±0.82   −5.97       *p\<*0.05
  2\.                                                  Acute                                       1                           6                     300                 36--43   39.33±0.23               
  3\.                                                  Control[\*](#TF0005){ref-type="table-fn"}   7                           6                     --                  42--44   42.67±0.36   −2.34       *p\>*0.05
  4\.                                                  Subchronic                                  7                           6                     10.7                38--46   41.67±0.36               
  5\.                                                  Control[\*](#TF0005){ref-type="table-fn"}   14                          6                     --                  40--46   42.5±0.73    −5.5        *p\<*0.05
  6\.                                                  Subchronic                                  14                          6                     10.7                38--42   40.16±0.71               
  7\.                                                  Control[\*](#TF0005){ref-type="table-fn"}   21                          6                     --                  38--45   43.33±0.54   −3.85       *p\<*0.05
  8\.                                                  Subchronic                                  21                          6                     10.7                36--44   41.66±0.78               
  9\.                                                  Control[\*](#TF0005){ref-type="table-fn"}   28                          6                     --                  38--45   42.67±0.54   −5.08       *p\<*0.05
  10\.                                                 Subchronic                                  28                          6                     10.7                38--42   40.5±0.68                
                                                                                                                                                                                                           
  Recovery group[\*\*](#TF0006){ref-type="table-fn"}                                                                                                                                                       
                                                                                                                                                                                                           
  a\.                                                  Control[\*](#TF0005){ref-type="table-fn"}   --                          6                     --                  37--44   42.67±0.36   −1.66       *p\>*0.05
  b\.                                                  Treated                                     --                          6                     10.7                36--45   41.96±0.54               

Controls were given groundnut oil only

Recovery group were given oil (a) and cypermethrin (b) treatment for 28 days and effects assessed after 60 days

###### 

Effect of Cypermethrin on Mean Corpuscular Volume (µ^3^) in *Rattus norvegicus.*

  S.No.                                                Treatment                                   Treatment duration (Days)   No. of rats treated   Dose (mg/kg b.w.)   Range        Mean±S.E.   \% change   Significance level
  ---------------------------------------------------- ------------------------------------------- --------------------------- --------------------- ------------------- ------------ ----------- ----------- --------------------
  1\.                                                  Control[\*](#TF0007){ref-type="table-fn"}   1                           6                     --                  58.6--65.8   61.8±1.29   −2.42       *p\>*0.05
  2\.                                                  Acute                                       1                           6                     300                 56.7--61.9   60.3±1.13               
  3\.                                                  Control[\*](#TF0007){ref-type="table-fn"}   7                           6                     --                  60.1--64.7   62.5±0.60   −1.44       *p\>*0.05
  4\.                                                  Subchronic                                  7                           6                     10.7                60.0--63.7   61.6±0.63               
  5\.                                                  Control[\*](#TF0007){ref-type="table-fn"}   14                          6                     --                  59.2--65.2   61.8±1.10   −0.16       *p\>*0.05
  6\.                                                  Subchronic                                  14                          6                     10.7                59.6--63.9   61.7±0.71               
  7\.                                                  Control[\*](#TF0007){ref-type="table-fn"}   21                          6                     --                  61.6--66.5   64.6±0.89   −6.34       *p\<*0.01
  8\.                                                  Subchronic                                  21                          6                     10.7                57.2--63.2   60.5±0.91               
  9\.                                                  Control[\*](#TF0007){ref-type="table-fn"}   28                          6                     --                  58.5--68.7   62.3±1.08   −3.53       *p\<*0.01
  10\.                                                 Subchronic                                  28                          6                     10.7                59.2--63.4   60.1±1.07               
                                                                                                                                                                                                              
  Recovery group[\*\*](#TF0008){ref-type="table-fn"}                                                                                                                                                          
                                                                                                                                                                                                              
  a\.                                                  Control[\*](#TF0007){ref-type="table-fn"}   --                          6                     --                  60.1--63.9   62.5±0.60   −1.12       *p\>*0.05
  b\.                                                  Treated                                     --                          6                     10.7                58.6--65.8   61.8±1.29               

Controls were given groundnut oil only

Recovery group were given oil (a) and cypermethrin (b) treatment for 28 days and effects assessed after 60 days

###### 

Effect of Cypermethrin on Mean Corpuscular Haemoglobin (pg) in *Rattus norvegicus*.

  S.No.                                                Treatment                                   Treatment duration (Days)   No. of rats treated   Dose (mg/kg b.w.)   Range          Mean±S.E.    \% change   Significance level
  ---------------------------------------------------- ------------------------------------------- --------------------------- --------------------- ------------------- -------------- ------------ ----------- --------------------
  1\.                                                  Control[\*](#TF0009){ref-type="table-fn"}   1                           6                     --                  16.08--22.29   18.56±0.39   −1.96       *p\>*0.05
  2\.                                                  Acute                                       1                           6                     300                 14.88--21.91   18.21±0.21               
  3\.                                                  Control[\*](#TF0009){ref-type="table-fn"}   7                           6                     --                  13.21--24.76   18.58±0.26   −1.43       P\>0.05
  4\.                                                  Subchronic                                  7                           6                     10.7                16.88--22.93   18.31±0.18               
  5\.                                                  Control[\*](#TF0009){ref-type="table-fn"}   14                          6                     --                  13.12--23.85   18.19±0.33   −2.69       P\<0.05
  6\.                                                  Subchronic                                  14                          6                     10.7                14.36--26.61   17.70±0.35               
  7\.                                                  Control[\*](#TF0009){ref-type="table-fn"}   21                          6                     --                  10.07--38.58   18.14±0.24   −2.92       P\>0.05
  8\.                                                  Subchronic                                  21                          6                     10.7                10.99--27.86   17.30±0.14               
  9\.                                                  Control[\*](#TF0009){ref-type="table-fn"}   28                          6                     --                  16.59--18.60   17.91±0.23   −7.03       P\>0.01
  10\.                                                 Subchronic                                  28                          6                     10.7                10.50--23.0    16.65±0.18               
                                                                                                                                                                                                                 
  Recovery group[\*\*](#TF0010){ref-type="table-fn"}                                                                                                                                                             
                                                                                                                                                                                                                 
  a\.                                                  Control[\*](#TF0009){ref-type="table-fn"}   --                          6                     --                  13.71--28.51   17.64±0.35   ±2.04       P\>0.05
  b\.                                                  Treated                                     --                          6                     10.7                14.29--28.56   18.0±0.26                

Controls were given groundnut oil only

Recovery group were given oil (a) and cypermethrin (b) treatment for 28 days and effects assessed after 60 days

###### 

Effect of Cypermethrin on Mean Corpuscular Haemoglobin Concentration (g/dl) in *Rattus norvegicus.*

  S.No.                                                Treatment                                   Treatment duration (Days)   No. of rats treated   Dose (mg/kg b.w.)   Range          Mean±S.E.    \% change   Significance level
  ---------------------------------------------------- ------------------------------------------- --------------------------- --------------------- ------------------- -------------- ------------ ----------- --------------------
  1\.                                                  Control[\*](#TF0011){ref-type="table-fn"}   1                           6                     --                  20.18--32.0    29.76±0.61   ±3.06       P\>0.05
  2\.                                                  Acute                                       1                           6                     300                 20.0--38.79    30.67±0.29               
  3\.                                                  Control[\*](#TF0011){ref-type="table-fn"}   7                           6                     --                  22.9--36.47    29.14±0.42   −1.44       P\>0.05
  4\.                                                  Subchronic                                  7                           6                     10.7                26.61--29.75   28.72±0.37               
  5\.                                                  Control[\*](#TF0011){ref-type="table-fn"}   14                          6                     --                  23.57--39.21   29.42±0.50   −1.57       P\>0.05
  6\.                                                  Subchronic                                  14                          6                     10.7                25.42--36.52   28.97±0.47               
  7\.                                                  Control[\*](#TF0011){ref-type="table-fn"}   21                          6                     --                  20.81--49.52   28.01±0.43   −3.07       P\>0.05
  8\.                                                  Subchronic                                  21                          6                     10.7                23.55--39.18   27.15±0.92               
  9\.                                                  Control[\*](#TF0011){ref-type="table-fn"}   28                          6                     --                  26.81--39.73   28.78±0.72   −1.49       P\>0.05
  10\.                                                 Subchronic                                  28                          6                     10.7                20.84--40.0    28.35±0.47               
                                                                                                                                                                                                                 
  Recovery group[\*\*](#TF0012){ref-type="table-fn"}                                                                                                                                                             
                                                                                                                                                                                                                 
  a\.                                                  Control[\*](#TF0011){ref-type="table-fn"}   --                          6                     --                  21.93--38.47   29.14±0.42   ±0.96       P\>0.05
  b\.                                                  Treated                                     --                          6                     10.7                19.57--48.29   29.42±0.50               

Controls were given groundnut oil only

Recovery group were given oil (a) and cypermethrin (b) treatment for 28 days and effects assessed after 60 days

###### 

Effect of Cypermethrin on Erythrocyte Sedimentation Rate (ESR) (mm 1^st^ hour) in *Rattus norvegicus.*

  S.No.                                                Treatment                                   Treatment duration (Days)   No. of rats treated   Dose (mg/kg b.w.)   Range   Mean±S.E.   \% change   Significance level
  ---------------------------------------------------- ------------------------------------------- --------------------------- --------------------- ------------------- ------- ----------- ----------- --------------------
  1\.                                                  Control[\*](#TF0013){ref-type="table-fn"}   1                           6                     --                  1--2    1.33±0.23   ±50.37      P\>0.05
  2\.                                                  Acute                                       1                           6                     300                 1--3    2.0±0.39                
  3\.                                                  Control[\*](#TF0013){ref-type="table-fn"}   7                           6                     --                  2--3    2.33±0.23   −21.46      P\>0.05
  4\.                                                  Subchronic                                  7                           6                     10.7                1--3    1.83±0.34               
  5\.                                                  Control[\*](#TF0013){ref-type="table-fn"}   14                          6                     --                  2--2    2.0±0.0     −25.0       P\>0.05
  6\.                                                  Subchronic                                  14                          6                     10.7                1--2    1.5±0.24                
  7\.                                                  Control[\*](#TF0013){ref-type="table-fn"}   21                          6                     --                  1--2    1.33±0.26   ±75.18      P\<0.05
  8\.                                                  Subchronic                                  21                          6                     10.7                2--3    2.33±0.23               
  9\.                                                  Control[\*](#TF0013){ref-type="table-fn"}   28                          6                     --                  2--2    2.0±0.0     0           P\>0.05
  10\.                                                 Subchronic                                  28                          6                     10.7                1--4    2.0±0.56                
                                                                                                                                                                                                         
  Recovery group[\*\*](#TF0014){ref-type="table-fn"}                                                                                                                                                     
                                                                                                                                                                                                         
  a\.                                                  Control[\*](#TF0013){ref-type="table-fn"}   --                          6                     --                  1--3    2.0±0.43    0           P\>0.05
  b\.                                                  Treated                                     --                          6                     10.7                2--2    2.0±0.0                 

Controls were given groundnut oil only

Recovery group were given oil (a) and cypermethrin (b) treatment for 28 days and effects assessed after 60 days

###### 

Effect of Cypermethrin on Total Leukocyte Count (thousand/mm^3^) in *Rattus norvegicus.*

  S.No.                                                Treatment                                   Treatment duration (Days)   No. of rats treated   Dose (mg/kg b.w.)   Range      Mean±S.E.   \% change   Significance level
  ---------------------------------------------------- ------------------------------------------- --------------------------- --------------------- ------------------- ---------- ----------- ----------- --------------------
  1\.                                                  Control[\*](#TF0015){ref-type="table-fn"}   1                           6                     --                  6.2--7.6   6.87±0.22   ±44         P\>0.05
  2\.                                                  Acute                                       1                           6                     300                 6.6--7.2   6.9±0.11                
  3\.                                                  Control[\*](#TF0015){ref-type="table-fn"}   7                           6                     --                  6.0--7.2   6.7±0.20    ±4.48       P\>0.05
  4\.                                                  Subchronic                                  7                           6                     10.7                6.8--7.4   7.0±0.13                
  5\.                                                  Control[\*](#TF0015){ref-type="table-fn"}   14                          6                     --                  6.2--7.5   6.87±0.91   ±17.61      P\<0.001
  6\.                                                  Subchronic                                  14                          6                     10.7                7.6--8.6   8.08±0.13               
  7\.                                                  Control[\*](#TF0015){ref-type="table-fn"}   21                          6                     --                  6.0--7.4   6.75±0.22   ±13.77      P\<0.01
  8\.                                                  Subchronic                                  21                          6                     10.7                7.6--7.8   7.68±0.04               
  9\.                                                  Control[\*](#TF0015){ref-type="table-fn"}   28                          6                     --                  6.3--7.6   7.05±0.07   ±12.76      P\<0.01
  10\.                                                 Subchronic                                  28                          6                     10.7                7.8--8.2   7.95±0.07               
                                                                                                                                                                                                            
  Recovery group[\*\*](#TF0016){ref-type="table-fn"}                                                                                                                                                        
                                                                                                                                                                                                            
  a\.                                                  Control[\*](#TF0015){ref-type="table-fn"}   --                          6                     --                  6.0--7.4   6.75±0.22   ±1.78       P\>0.05
  b\.                                                  Treated                                     --                          6                     10.7                6.2--7.4   6.87±0.19               

Controls were given groundnut oil only

Recovery group were given oil (a) and cypermethrin (b) treatment for 28 days and effects assessed after 60 days

###### 

Effect of Cypermethrin on Bone Marrow Counts for Myeloid-Erythroid ratio in *Rattus norvegicus.*

  S.No.                                                Treatment                                   Treatment duration (Days)   No. of rats treated   Dose (mg/kg b.w.)   Myeloid   Erythroid   M-E Ratio                                
  ---------------------------------------------------- ------------------------------------------- --------------------------- --------------------- ------------------- --------- ----------- ----------- -------- --------- --------- --------
  1\.                                                  Control[\*](#TF0017){ref-type="table-fn"}   1                           6                     --                  70--77    74±0.23     P\>0.05     20--32   26±0.76   P\>0.05   2.84:1
  2\.                                                  Acute                                       1                           6                     300                 68--75    72±0.61                 21--32   28±0.57             2.57:1
  3\.                                                  Control[\*](#TF0017){ref-type="table-fn"}   7                           6                     --                  64--80    75±0.77     P\<0.05     22--29   25±0.98   P\<0.05   3:1
  4\.                                                  Subchronic                                  7                           6                     10.7                61--73    67±0.85                 25--36   33±0.73             2.03:
  5\.                                                  Control[\*](#TF0017){ref-type="table-fn"}   14                          6                     --                  64--80    74±0.26     P\<0.05     20--31   26±0.31   P\<0.05   2.84:1
  6\.                                                  Subchronic                                  14                          6                     10.7                58--69    65±0.53                 31--39   35±0.24             1.85:1
  7\.                                                  Control[\*](#TF0017){ref-type="table-fn"}   21                          6                     --                  65--82    73±0.42     P\<0.05     22--29   27±1.21   P\<0.05   2.70:1
  8\.                                                  Subchronic                                  21                          6                     10.7                54--65    61±0.96                 25--42   39±0.64             1.56:1
  9\.                                                  Control[\*](#TF0017){ref-type="table-fn"}   28                          6                     --                  70--79    76±1.04     P\<0.01     19--28   24±1.02   P\<0.01   3.16:1
  10\.                                                 Subchronic                                  28                          6                     10.7                48--57    55±0.75                 38--49   45±0.43             1.2:1
                                                                                                                                                                                                                                        
  Recovery group[\*\*](#TF0018){ref-type="table-fn"}                                                                                                                                                                                    
                                                                                                                                                                                                                                        
  a\.                                                  Control[\*](#TF0017){ref-type="table-fn"}   --                          6                     --                  72--78    75±0.98     P\>0.05     21--28   25±0.57   P\>0.05   3:1
  b\.                                                  Treated                                     --                          6                     10.7                71--80    76±1.10                 20--26   24±0.98             3.16:1

Controls were given groundnut oil only

Recovery group were given oil (a) and cypermethrin (b) treatment for 28 days and effects assessed after 60 days

###### 

Effect of Cypermethrin on Differential Leukocyte Count in *Rattus norvegicus.*

  Cell type                                      Treatment   No. of days   Control[\*](#TF0019){ref-type="table-fn"}   Treatment    \% Change    Significance               
  ---------------------------------------------- ----------- ------------- ------------------------------------------- ------------ ------------ -------------- ----------- -----------
  Neutrophils                                    Acute       1             24-28                                       26.0±0.78    23-27        25.28±1.23     -0.46       P\>0.05
  Subchronic                                     7           26-30         28.22±1.73                                  28-41        30.12±2.60   ±6.73          P\<0.05     
                                                 14          23-29         26.00±1.73                                  32-41        36.66±2.60   ±41            P\<0.05     
                                                 21          28-30         29.33±0.67                                  33-36        34.33±1.2    ±17.05         P\<0.01     
                                                 28          27-30         28.22±0.63                                  29-33        32.0±1.42    ±13.39         P\<0.01     
  Recovery[\*\*](#TF0020){ref-type="table-fn"}   60          25-28         27.10±0.75                                  24-27        26.87±0.65   -0.52          P\>0.05     
  Eosinophils                                    Acute       1             2-4                                         3.30±0.75    2-5          4.04±0.64      ±32.89      P\>0.05
  Subchronic                                     7           2-3           2.21±0.47                                   1-3          2.46±0.07    ±11.31         P\>0.05     
                                                 14          1-3           1.93±0.86                                   2-4          2.34±0.98    ±21.24         P\>0.05     
                                                 21          1-3           2.00±0.54                                   1-3          2.00±0.54    \-             P\>0.05     
                                                 28          2-3           2.65±1.16                                   1-3          2.00±0.65    -24            P\>0.05     
  Recovery[\*\*](#TF0020){ref-type="table-fn"}   60          2-4           2.28±0.64                                   1-3          1.69±0.81    -28.99         P\>0.05     
  Lymphocytes                                    Acute       1             65-73                                       70.08±0.57   67-72        70.68±1.31     -0.28       P\>0.05
  Subchronic                                     7           67-71         69.57±0.45                                  66-70        67.42±0.72   -3.09          P\>0.05     
                                                 14          67-72         71.40±1.64                                  58-63        61.0±0.89    -14.56         P\>0.05     
                                                 21          67-70         68.67±0.88                                  63-64        63.67±0.58   -7.06          P\<0.01     
                                                 28          66-70         69.13±0.65                                  63-68        64.25±1.63   -7.06          P\<0.01     
  Recovery[\*\*](#TF0020){ref-type="table-fn"}   60          65-72         70.62±0.97                                  66-72        70.70±1.20   ±0.13          P\>0.05     
  Monocytes                                      Acute       1             00-01                                       0.68±0.35    0            0              0           No change
                                                 7           00            0                                           0            0            0              No change   
  Subchronic                                     14          0-1           0.62±0.33                                   1-2          1.03±0.74    ±0.53.73       P\>0.05     
                                                 21          0             0                                           0            0            0              No change   
                                                 28          0             0                                           0            0            0              No change   
  Recovery[\*\*](#TF0020){ref-type="table-fn"}   60          0             0                                           0            0.73±0.03    \-             P\>0.05     

Controls were given groundnut oil only

Recovery group were given oil (a) and cypermethrin (b) treatment for 28 days and effects assessed after 60 days

Qualitative changes {#S20010}
-------------------

Qualitative changes in blood included crenated, hypochromatic red blood cells, microcystosis, appearance of stomatocytes, poikilocytosis, giant platelet formation and hyepersegmented neutrophils ([Plate I](#F0001){ref-type="fig"}--[X](#F0010){ref-type="fig"}), whereas those of bone marrow included increased appearance of immature haematological precursors such as orthochromatic and polychromatic erythroblasts, megaloblasts, myeloblasts, polymorphonuclear neutrophils ([Plate XI](#F0011){ref-type="fig"}--[XVII](#F0017){ref-type="fig"}).

![Photomicrograph of peripheral blood film of *Rattus norvegicus* of control group showing normal red blood cells.](ITX-7-033-g001){#F0001}

![Photomicrograph of peripheral blood film of *Rattus norvegicus* after acute (1 day) cypermethrin treatment showing crenated red blood cells (CRBC).](ITX-7-033-g001){#F0002}

![Photomicrograph of peripheral blood film of *Rattus norvegicus* after 7 days of subchronic treatment with cypermethrin showing stomatocyte (ST) and normal neutrophils (NP).](ITX-7-033-g001){#F0003}

![Photomicrograph of peripheral blood film of *Rattus norvegicus* after 14 days of subchronic treatment with cypermethrin showing giant platelet (GP), large lymphocyte (LL) and microcytes (MC).](ITX-7-033-g001){#F0004}

![Photomicrograph of peripheral blood film of *Rattus norvegicus* after 21 days of subchronic treatment showing hypochromatic red blood cell (HRBC).](ITX-7-033-g001){#F0005}

![Photomicrograph of peripheral blood film of *Rattus norvegicus* after 28 days of subchronic treatment with cypermethrin showing microcytes (MC) and acanthocytes (A).](ITX-7-033-g001){#F0006}

![Photomicrograph of peripheral blood film of *Rattus norvegicus* of recovery group showing appearance of normal red blood cells (NRBC).](ITX-7-033-g001){#F0007}

![Photomicrograph of peripheral blood film of *Rattus norvegicus* after cypermethrin treatment showing target cell (TC) and basophilic normoblast (BN).](ITX-7-033-g001){#F0008}

![Photomicrograph of peripheral blood film of *Rattus norvegicus* after cypermethrin treatment showing natural killer cell (NKC) and giant platelet (GP).](ITX-7-033-g001){#F0009}

![Photomicrograph of peripheral blood film of *Rattus norvegicus* after cypermethrin treatment showing hypersegmented neutrophil (HN).](ITX-7-033-g001){#F0010}

![Photomicrograph of bone marrow smear of *Rattus norvegicus* of control group depicting promyelocyte (PMC) and polychromatic erythroblast (PE).](ITX-7-033-g002){#F0011}

![Photomicrograph of bone marrow smear of *Rattus norvegicus* after acute cypermethrin treatment showing orthochromatic erythroblast (OE).](ITX-7-033-g002){#F0012}

![Photomicrograph of bone marrow smear of *Rattus norvegicus* after 7 days of cypermethrin treatment showing megaloblast (MB) and slight increase in cells of erythroid series.](ITX-7-033-g002){#F0013}

![Photomicrograph of bone marrow smear of *Rattus norvegicus* after subchronic (14 days) cypermethrin treatment showing polychromatic erythroblast (PE) and increase in erythroid precursors.](ITX-7-033-g002){#F0014}

![Photomicrograph of bone marrow smear of *Rattus norvegicus* after subchronic (21 days) cypermethrin treatment depicting myelocyte (MC) and moderate increase in erythroid precursors.](ITX-7-033-g002){#F0015}

![Photomicrograph of bone marrow smear of *Rattus norvegicus* after subchronic (28 days) treatment showing metamyelocyte (MMC) band stage (B), polymorphonuclear neutrophils (PMN) and highly increased proportion of erythroid cells.](ITX-7-033-g002){#F0016}

![Photomicrograph of bone marrow smear of *Rattus norvegicus* of recovery group (60 days) showing developing neutrophils (NP), polymorphonuclear eosinophil (PNE) and polymorphonuclear basophil (PNB).](ITX-7-033-g002){#F0017}

Discussion {#S0011}
==========

Haematological evaluation is one of the best methods to assess toxicity of pyrethroids. Pyrethroids can induce toxicity to various haematological components in two ways, either by interference with mature components flowing in peripheral blood or with development of such integral blood components (Pande, [@CIT0015]; Saka *et al.,* [@CIT0017]; Bhushan *et al.,* [@CIT0008]).

Of the circulating elements of blood, a decrease found in total red cell count in the present study following cypermethrin intoxication is an indicator of interference of the experimental compound as well as its metabolically broken-down byproducts. This interference may be in the form of destruction of the normal erythrocytic membrane structure causing lysis of erythrocytes resulting in this decrease (Sakoori *et al.,* [@CIT0020]; Ahmad *et al.,* [@CIT0003]; Abbassy & Mossa, [@CIT0001]). Pyrethroids, including cypermethrin, are also capable of causing alterations in blood forming organs of albino rats (Singh & Saxena, [@CIT0021]; Assayed *et al.,* [@CIT0005]; Lamfon, [@CIT0014]). Qualitatively, stomatocytes, hypochromasia and poikilocytosis seen in blood smears of cypermethrin intoxicated rats along with the presence of various immature erythrocytic precursors in bone marrow smears, are indicative of haemolysis and erythrocytic membrane abnormalities as well as of bone marrow dysfunction. Reduction in the number of RBCs is thus an outcome of haemolysis of red blood cells observed qualitatively and quantitatively as well as of a possible dysfunction of bone marrow, which was apparent qualitatively.

Further, a significant decrease in RBC count was also accompanied with decrease in haemoglobin concentration following cypermethrin intoxication in the present investigation. Microcytosis and hypochromasia, apparent qualitatively, is an indicator of impaired haemoglobin synthesis. Therefore decrease in haemoglobin concentration registered under pyrethroid stress is the result of a reduction in the number of red blood cells due to erythrocytopenia and impaired haemoglobin synthesis in the erythroblasts (Sakoori *et al.,* [@CIT0020]; Jain *et al.,* [@CIT0013]; Abbassy & Mossa, [@CIT0001]).

Decrease in PCV, as reported in the present study, can also be correlated with reduced RBC count coupled with hypohaemoglobinaemia accompanied by hypoplasia of bone marrow and dilutional anaemia (Pande, [@CIT0015]; Jain *et al.,* [@CIT0013]; Abbassy & Mossa, [@CIT0001]).

The mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH) and mean corpuscular haemogloin concentration (MCHC) are generally referred to as absolute values. These values indicate abnormalities in the erythrocytes and their calculation is widely used in the classification of anaemia under pathological conditions (Dacie & Lewis, [@CIT0011]). A significant decline in MCV is also an outcome of cypermethrin induced toxicity to bone marrow which is producing microcytes along with exosmosis due to electrolyte imbalance. Decrease in the value of MCH may be attributed to microcytic anaemia following cypermethrin intoxication quantitatively and hypochromasia qualitatively.

Non-significant but generalised decrease in MCHC value seems to be the result of microcytosis of red blood cells. Since MCHC represents inverse relationship with PCV and haemoglobin levels, a decrease in values of both these parameters in intoxicated experimental rats nullified the effect of eachothers and thus MCHC showed a non-significant effect (Pande, [@CIT0015]).

ESR values were also elevated non-significantly, which however is an indicator of inflammatory manifestation and gains support by rise in TLC following cypermethrin intoxication. Leukocytosis may be regarded as the body\'s response to the invasion of a foreign substance into the body (Saxena & Tomar, [@CIT0018]). Further, increase in TLC in the present study was mainly due to the increase in neutrophils, which are granulocytes of bone marrow origin. Increased neutrophil count may be an outcome of stimulated granulocyte precursors to produce more and more of these cells, while cytotoxic effects of cypermethrin on the spleen, the site where lymphocytes are formed, resulted in lymphoma in cypermethrin treated rats. The rise in TLC may be due to qualitative responses such as hyper-segmentation in neutrophils, a consequence of disordered granulopoiesis, presence of natural killer cells in peripheral blood and formation of giant platelets.

Qualitatively, microcytosis, poikilocytosis, stomatocytosis, hypochromasia, hypersegmentation and giant platelet formation in peripheral blood and the presence of various altered precursors in bone marrow smears are strong indicators of the haematotoxic potential of cypermethrin at both functional and developmental levels of blood components.

Further the reversal of altered values towards normalcy after the recovery phase of twenty-two days points to a time-based process.
